Integral Derivatives’s CME Group CME Stock Holding History

Integral Derivatives’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,700	Closed	-$311K	–	1186
2016 Q4	$311K	Sell	2,700 -1,200	-31%	-$134K	0.01%	867
2016 Q3	$408K	Sell	3,900 -400	-9%	-$41.8K	0.01%	691
2016 Q2	$419K	Buy	+4,300	New	+$406K	0.01%	651
2015 Q3	–	Sell	-10,000	Closed	-$931K	–	1109
2015 Q2	$931K	Buy	+10,000	New	+$933K	0.03%	546

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Integral Derivatives's CME Position: Q4 2017 in Review

Integral Derivatives sold out of CME Group (CME) in Q4 2017, closing a stake of 2,648 shares — an estimated $377K sold.

Integral Derivatives first reported a position in CME in Q4 2014 and held it in 2 quarters. The position peaked at $359K in Q3 2017. 855 funds tracked by Wall St. Rank hold CME as of Q4 2017.

Integral Derivatives reported no remaining CME Group position as of Q4 2017 after selling out during the quarter.
Integral Derivatives sold 2,648 CME Group shares in Q4 2017, an estimated $377K.
Integral Derivatives first reported a position in CME Group in Q4 2014 and held it in 2 quarters.
Integral Derivatives's CME Group position peaked at $359K in Q3 2017.
855 funds tracked by Wall St. Rank held CME Group as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.